Two Sigma Investments

Two Sigma Investments’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Two Sigma Investments’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-302,015	Closed	-$268K	–	3348
2022 Q4	$268K	Hold	302,015	–	–	﹤0.01%	2285
2022 Q3	$474K	Hold	302,015	–	–	﹤0.01%	1803
2022 Q2	$607K	Sell	302,015 -786,685	-72%	-$1.36M	﹤0.01%	1745
2022 Q1	$2.54M	Buy	+1,088,700	New	+$3.4M	0.01%	1232
2015 Q2	–	Sell	-73,035	Closed	-$844K	–	3228
2015 Q1	$844K	Buy	73,035 +41,158	+129%	+$476K	﹤0.01%	1682
2014 Q4	$321K	Buy	+31,877	New	+$161K	﹤0.01%	1899

Other funds holding SRNE

Paloma Partners Greenwich, Connecticut $177M AUM 286.05% 1-Year Est. Return

Oaktree Capital Management Los Angeles, California $5.91B AUM 42.97% 1-Year Est. Return

Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return

Crescent Grove Advisors Lake Forest, Illinois $1.01B AUM 17.78% 1-Year Est. Return

Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return

S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return

Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return